Peter Toth, Md: Glp-1 Agonists And Sglt-2 Inhibitors For Diabetes

Peter Toth, MD: GLP-1 Agonists and SGLT-2 Inhibitors for Diabetes

Diabetes and Cardiovascular Disease, SGLT2 inhibitors and GLP1 receptor agonists with Dr. Peter Toth

Future Pulse Cardiology

Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists

Harvard Medical School Continuing Education

SGLT2 Inhibitors vs GLP-1 Agonists: A Cardiologist and an Endocrinologist Weigh In

EFL033 - GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes

Endocrine Society

Jeffrey Berger, MD: Deciding Between GLP1 Agonists or SGLT2 Inhibitors

Role of GLP-1 Receptor Agonists for Weight Loss

Harvard Medical School Continuing Education

Robert Gabbay, MD, PhD: The Debate About SGLT-2 Inhibitors and GLP-1 Receptor Agonists

Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek]

GLP 1, Mounjaro, Wegovy & Ozempic: How These Affect Weight Loss & Metabolic Health | Dr. Rob Lustig

Transforming Diabetes Care: Discover the Power of SGLT2 Inhibitors and GLP-1 Agonists

TheRightDoctors

Understanding How SGLT2 Inhibitors and GLP-1 Agonists Work - Medpage Today

Prof Melanie Davies - 'Do GLP-1 analogues and SGLT2 inhibitors have a role beyond type 2 diabetes?'

At the Limits - Leading Medical Education

Is One SGLT2 (Or GLP-1) Just Like Another for Cardiac Benefit?

Dr Darren K. McGuire Discusses Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in T2D

Using GLP-1 Agonists in Patients With T2D and CVD

GLP-1 Agonists for Weight Loss: A Side-by-Side Comparison

Dr. Brian Yeung, ND

Prescribing GLP-1 Receptor Agonists for Weight Loss

Harvard Medical School Continuing Education

An Oral GLP-1 Receptor Agonist for Adults with Obesity | NEJM

SGLT-2 I, Natriuresis & Aquaresis: DAPA Shuttle-1 - Dr. A. Marton and Prof. Dr. J. Titze (Singapore)